XPF-001

DRUG3 trials

Sponsors

Xenon Pharmaceuticals Inc.

Conditions

Dental PainHealthy Human VolunteersInherited ErythromelalgiaPrimary Erythromelalgia

Phase 1

Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers

CompletedNCT00813670

Xenon Pharmaceuticals Inc.Healthy Human Volunteers

Start: 2008-11-30End: 2009-07-31Target: 64Updated: 2009-09-14

Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)

CompletedNCT01090622

Xenon Pharmaceuticals Inc.Inherited Erythromelalgia, Primary Erythromelalgia

Start: 2010-04-30End: 2010-09-30Updated: 2012-03-16

Phase 2

Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction

CompletedNCT00954356

Xenon Pharmaceuticals Inc.Dental Pain

Start: 2009-09-30End: 2009-12-31Updated: 2012-07-16